🔎 Trials Near Me

Akèy › Timè nan sèvo › Kalifòni › San Francisco

Etid klinik pou Timè nan sèvo nan San Francisco, CA

8 etid pou Timè nan sèvo ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Ap rekriteFaz 1/2
  • University of California, San Francisco (UCSF), San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Ap rekriteFaz 2
  • Local Institution - 0096, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07492680

Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

Ap rekriteEtid obsèvasyon
  • University of California, San Francisco, San Francisco
Laj 4 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06474533

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Ap rekriteEtid obsèvasyon
  • California Pacific Medical Center, Sutter health, San Francisco
Tout laj · Tout sèks · Mizajou Jul 22, 2026 · NCT04427384

Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of California San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou May 19, 2026 · NCT07418775

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Ap rekriteFaz 1/2
  • University of California at San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT06810544

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Ap rekriteEtid obsèvasyon
  • University of California, San Francisco, San Francisco
Jiska laj 90 · Tout sèks · Mizajou Feb 22, 2024 · NCT06273176

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

Ap rekriteEtid obsèvasyon
  • University of California, San Francisco (UCSF), San Francisco
Laj 18 a 90 · Tout sèks · Mizajou Feb 22, 2024 · NCT06118723

Etid Timè nan sèvo nan lòt vil

Lòt etid nan San Francisco

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.